Abstract
Immune blistering diseases may involve the cutaneous or mucosal surfaces of the female genital structures. Blisters that form on mucosal surfaces erode quickly and appear more commonly as erosions. Diagnosis requires a thorough history and full examination of all cutaneous and mucosal sites to identify lesions that may be asymptomatic, healing, or hidden from view. Histology and direct immunofluorescence of a biopsy taken from the edge of a blister or erosion are necessary to diagnose and differentiate these diseases. An important characteristic is the location of blister formation: subepidermal or intraepidermal.
Management principles and recommended medications overlap for many of the immune blistering diseases; where specific differences exist, notations are made with the description of the disease. Systemic steroids or other immune-suppressive medication are often indicated. The use of topical steroids is occasionally sufficient and should be considered for vulvar skin lesions, especially in disease that is otherwise well-controlled. General care of the vulvar skin should include a review of basic guidelines with emphasis on soaks and barriers or skin protectants. Close follow-up and examination of cutaneous and mucosal surfaces are warranted for surveillance as many of these diseases are prone to recur.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Schmidt E, Zillikens D. Pemphigoid diseases. Lancet. 2013;381(9863):320–32.
Bifulco G, Mandato VD, Piccoli R, Giampaolino P, Mignogna C, Mignogna MD, et al. Early invasive vulvar squamous cell carcinoma arising in a woman with vulvar pemphigus vulgaris and systemic lupus erythematosus. BMC Cancer. 2010;10:324.
Goldstein AT, Anhalt GJ, Klingman D, Burrows LJ. Mucous membrane pemphigoid of the vulva. Obstet Gynecol. 2005;105(5 Pt 2):1188–90.
Huilaja L, Makikallio K, Hannula-Jouppi K, Vakeva L, Hook-Nikanne J, Tasanen K. Cyclosporine treatment in severe gestational pemphigoid. Acta Derm Venereol. 2015;95(5):593–5.
Malakar S, Saha A. Successful treatment of resistant Lichen Planus Pemphigoides with cyclosporine: a new hope. Indian J Dermatol. 2016;61(1):112–4.
Antiga E, Caproni M. The diagnosis and treatment of dermatitis herpetiformis. Clin Cosmet Investig Dermatol. 2015;8:257–65.
Contestable JJ, Edhegard KD, Meyerle JH. Bullous systemic lupus erythematosus: a review and update to diagnosis and treatment. Am J Clin Dermatol. 2014;15(6):517–24.
Barbosa WS, Rodarte CM, Guerra JG, Maciel VG, Fleury Junior LF, Costa MB. Bullous systemic lupus erythematosus: differential diagnosis with dermatitis herpetiformis. An Bras Dermatol. 2011;86(4 Suppl 1):S92–5.
Lebeau S, Mainetti C, Masouye I, Saurat JH, Borradori L. Localized childhood vulval pemphigoid treated with tacrolimus ointment. Dermatology. 2004;208(3):273–5.
Gunther C, Wozel G, Meurer M, Pfeiffer C. Topical tacrolimus treatment for cicatricial pemphigoid. J Am Acad Dermatol. 2004;50(2):325–6.
Howell E, Johnson SM. Venous thrombosis occurring after initiation of thalidomide for the treatment of cicatricial pemphigoid. J Drugs Dermatol. 2004;3(1):83–5.
Nguyen T, Alraqum E, Razzaque Ahmed A. Positive clinical outcome with IVIg as monotherapy in recurrent pemphigoid gestationis. Int Immunopharmacol. 2015;26(1):1–3.
Pipkin C. Erosive diseases of the vulva. Dermatol Clin. 2010;28(4):737–51.
Lebeau S, Braun RP, Masouye I, Perrinaud A, Harms M, Borradori L. Acquired melanocytic naevus in childhood vulval pemphigoid. Dermatology. 2006;213(2):159–62.
Urano S. Localized bullous pemphigoid of the vulva. J Dermatol. 1996;23(8):580–2.
Levine V, Sanchez M, Nestor M. Localized vulvar pemphigoid in a child misdiagnosed as sexual abuse. Arch Dermatol. 1992;128(6):804–6.
Stage AH, Humeniuk JM, Easley WK. Bullous pemphigoid of the vulva: a case report. Am J Obstet Gynecol. 1984;150(2):169–70.
Ridley CM. Cicatricial pemphigoid of the vulva. Am J Obstet Gynecol. 1985;152(7 Pt 1):916–7.
Leonard N, Biswas A, Hickey S, Bell H. Eosinophilic spongiosis in a case of lichen sclerosus: a marker for superimposed bullous pemphigoid? Histopathology. 2008;52(7):885–7.
Farrell AM, Kirtschig G, Dalziel KL, Allen J, Dootson G, Edwards S, et al. Childhood vulval pemphigoid: a clinical and immunopathological study of five patients. Br J Dermatol. 1999;140(2):308–12.
Marren P, Wojnarowska F, Venning V, Wilson C, Nayar M. Vulvar involvement in autoimmune bullous diseases. J Reprod Med. 1993;38(2):101–7.
Wojnarowska F, Marsden RA, Bhogal B, Black MM. Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap. J Am Acad Dermatol. 1988;19(5 Pt 1):792–805.
Edwards S, Wojnarowska F, Armstrong LM. Chronic bullous disease of childhood with oral mucosal scarring. Clin Exp Dermatol. 1991;16(1):41–3.
Chan LS, Ahmed AR, Anhalt GJ, Bernauer W, Cooper KD, Elder MJ, et al. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol. 2002;138(3):370–9.
Edwards L, Hays S. Vulvar cicatricial pemphigoid as a lichen sclerosus imitator. A case report. J Reprod Med. 1992;37(6):561–4.
Marren P, Walkden V, Mallon E, Wojnarowska F. Vulval cicatricial pemphigoid may mimic lichen sclerosus. Br J Dermatol. 1996;134(3):522–4.
Hoque SR, Patel M, Farrell AM. Childhood cicatricial pemphigoid confined to the vulva. Clinical. Dermatology. 2005;31:63–4.
Sadik CD, Lima AL, Zillikens D. Pemphigoid gestationis: toward a better understanding of the etiopathogenesis. Clin Dermatol. 2016;34(3):378–82.
Jenkins RE, Hern S, Black MM. Clinical features and management of 87 patients with pemphigoid gestationis. Clin Exp Dermatol. 1999;24(4):255–9.
Chi CC, Wang SH, Charles-Holmes R, Ambros-Rudolph C, Powell J, Jenkins R, et al. Pemphigoid gestationis: early onset and blister formation are associated with adverse pregnancy outcomes. Br J Dermatol. 2009;160(6):1222–8.
Sitaru C, Powell J, Messer G, Brocker EB, Wojnarowska F, Zillikens D. Immunoblotting and enzyme-linked immunosorbent assay for the diagnosis of pemphigoid gestationis. Obstet Gynecol. 2004;103(4):757–63.
Zaraa I, Mahfoudh A, Sellami MK, Chelly I, El Euch D, Zitouna M, et al. Lichen planus pemphigoides: four new cases and a review of the literature. Int J Dermatol. 2013;52(4):406–12.
Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677–86.
Camisa C. Vesiculobullous systemic lupus erythematosus. A report of four cases. J Am Acad Dermatol. 1988;18(1 Pt 1):93–100.
Miziara ID, Mahmoud A, Chagury AA, Alves RD. Bullous systemic lupus Erythematosus: case report. Int Arch Otorhinolaryngol. 2013;17(3):344–6.
Pinto-Sanchez MI, Bercik P, Verdu EF, Bai JC. Extraintestinal manifestations of celiac disease. Dig Dis. 2015;33(2):147–54.
Malik M, Ahmed AR. Involvement of the female genital tract in pemphigus vulgaris. Obstet Gynecol. 2005;106(5 Pt 1):1005–12.
Lopez-Jornet P, Bermejo-Fenoll A. Gingival lesions as a first symptom of pemphigus vulgaris in pregnancy. Br Dent J. 2005;199(2):91–2.
Fairbanks Barbosa ND, de Aguiar LM, Maruta CW, Aoki V, Sotto MN, Labinas GH, et al. Vulvo-cervico-vaginal manifestations and evaluation of Papanicolaou smears in pemphigus vulgaris and pemphigus foliaceus. J Am Acad Dermatol. 2012;67(3):409–16.
Kavala M, Topaloglu Demir F, Zindanci I, Can B, Turkoglu Z, Zemheri E, et al. Genital involvement in pemphigus vulgaris (PV): correlation with clinical and cervicovaginal pap smear findings. J Am Acad Dermatol. 2015;73(4):655–9.
Batta K, Munday PE, Tatnall FM. Pemphigus vulgaris localized to the vagina presenting as chronic vaginal discharge. Br J Dermatol. 1999;140(5):945–7.
Wieselthier JS, Pincus SH. Hailey-Hailey disease of the vulva. Arch Dermatol. 1993;129(10):1344–5.
de Jesus LE, Dekermacher S, Manhaes CR, Faria LM, Barros ML. Acquired labial sinechiae and hydrocolpos secondary to Stevens-Johnson syndrome. Urology. 2012;80(4):919–21.
Ting HC, Adam BA. Stevens-Johnson syndrome. A review of 34 cases. Int J Dermatol. 1985;24(9):587–91.
Wain EM, Neill S. Fixed drug eruption of the vulva secondary to fluconazole. Clin Exp Dermatol. 2008;33(6):784–5.
Fischer G. Vulvar fixed drug eruption. A report of 13 cases. J Reprod Med. 2007;52(2):81–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Shaffer, S., Stockdale, C.K. (2019). Immune Blistering Disorders. In: Bornstein, J. (eds) Vulvar Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-61621-6_45
Download citation
DOI: https://doi.org/10.1007/978-3-319-61621-6_45
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-61620-9
Online ISBN: 978-3-319-61621-6
eBook Packages: MedicineMedicine (R0)